Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.21 USD | +0.55% | -1.39% | -17.91% |
Business Summary
Number of employees: 29
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100.0
%
| 2 | 100.0 % | 29 | 100.0 % | +1,335.37% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 29 | 100.0 % | +1,335.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 06/07/09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 06/07/09 |
Chief Tech/Sci/R&D Officer | - | - | |
Adrian Haigh
COO | Chief Operating Officer | 64 | 24/04/14 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 31/10/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 24/08/11 |
Khalid Islam
CHM | Chairman | 67 | 24/04/14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 06/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 24/04/14 |
Marco Brughera
BRD | Director/Board Member | 70 | 09/08/16 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 06/07/09 |
Jodi Cook
BRD | Director/Board Member | 56 | 23/09/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,099,908 | 22,955,300 ( 84.71 %) | 0 | 84.71 % |
Company contact information
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.91% | 250M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- FENC Stock
- Company Fennec Pharmaceuticals Inc.